Investor Letter

Showing 3560 articles
Business

Galenica's Five-Year Surge: A 90% Return for Patient Investors

Swiss healthcare group Galenica has delivered robust returns for long-term shareholders, with a total return of 90% over five years, significantly outpacing the broader market. While recent performance has moderated, the stock's journey highlights the value of consistent earnings growth and dividends.

Business

Raymond James Financial Insiders Cash Out: A Signal for Investors?

A wave of insider selling at Raymond James Financial, including an $18 million sale by its Executive Chair, is drawing scrutiny from the market. While high insider ownership remains a positive, the lack of any recent buying activity raises questions about internal confidence in the stock's near-term valuation.